Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AZNCF - Suspending Vaccine IP Rights Could Sink Moderna Novavax

AZNCF - Suspending Vaccine IP Rights Could Sink Moderna Novavax

AstraZeneca Plc
  • President Biden is contemplating suspending intellectual property rights for COVID-19 vaccines.
  • The sooner we vaccinate the entire world, the closer we get to protecting ourselves against COVID-19 and, potentially, new strains.
  • I value MRNA and NVAX based on 1x expected 2022 revenue, plus cash.
  • I estimate MRNA and NVAX are overvalued by 65% and 50%, respectively. Once the market digests this, this stocks could fall hard.
  • Generic competition could make matters worse. Sell MRNA and NVAX.

For further details see:

Suspending Vaccine IP Rights Could Sink Moderna, Novavax
Stock Information
Company Name: AstraZeneca Plc
Stock Symbol: AZNCF
Market: OTC
Website: astrazeneca.com
Menu
AZNCF AZNCF Quote AZNCF Short AZNCF News AZNCF Articles AZNCF Message Board
Get AZNCF Alerts

News, Short Squeeze, Breakout and More Instantly...